Cointime

NeuroNascent

company

About

Neuronascent discovers and develops small molecule therapeutics for depression and neurodegenerative diseases.

  • 1 - 10

Highlights

Total Funding Amount
$50K
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$50K
Industries
Biotechnology,Life Science,Medical,Therapeutics
Founded date
Jan 1, 2004
Number Of Employee
1 - 10
Operating Status
Active

Neuronascent discovers and develops first-in-class, small-molecule therapeutics, based on the science of neurogenesis, that target depression, neurodegenerative diseases, including Alzheimer's and Parkinson's, and Down syndrome. The Company is headquartered in Clarksville, MD and has facilities in Rockville and Walkersville, MD.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50K
NeuroNascent has raised a total of $50K in funding over 2 rounds. Their latest funding was raised on Jan 23, 2008 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 23, 2008 Grant $50K 1 Maryland Department of Business and Economic Development — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
NeuroNascent is funded by 1 investors. Maryland Department of Business and Economic Development are the most recent investors.
Investor Name Lead Investor Funding Round
Maryland Department of Business and Economic Development Yes Grant
Cointime
Содержание
компания